Actionable insights on equities, fixed-income, macros and personal finance Start 14-Days Free Trial
Actionable investing insights Get Free Trial

Abbott India

Industry Pharmaceuticals

Code NSE: ABBOTINDIA | BSE: 500488

Market Cap Rs 33,630Cr (USD 4.41 Bn)

1 Yr Return +115%

CMP First Reached -

Date Added 7th April 2020

CM Framework Reasonably Valued Core

CMP Rs 16,699

Recommendation Buy

  Why we like this stock:

Expensive but very strong MNC Owned Pharma stock Owns big OTC brands like Brufen, Digene, Thyronorm (thyroid) etc Also big on certain drugs like Duphaston (infertility), Vertin (Vertigo) and licensed vaccines ROE of 24% and profit growth of 22% CAGR in 10 years

Like our content? Join Capitalmind Premium.

  • Equity, fixed income, macro and personal finance research
  • Model equity and fixed-income portfolios
  • Exclusive apps, tutorials, and member community
Subscribe Now Or start with a free-trial